Ning Shi

2.2k total citations
124 papers, 1.5k citations indexed

About

Ning Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ning Shi has authored 124 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 31 papers in Pulmonary and Respiratory Medicine and 31 papers in Oncology. Recurrent topics in Ning Shi's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Ning Shi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Ning Shi collaborates with scholars based in China, United States and Japan. Ning Shi's co-authors include Shi‐You Chen, Xia Guo, Yiping Zou, Baohua Hou, Tingting Ma, Man-Ping Wu, Haosheng Jin, Wei‐Bing Xie, Haifeng Lian and Zhihong Chen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Circulation Research.

In The Last Decade

Ning Shi

111 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Shi China 23 768 432 279 262 254 124 1.5k
Xianxian Wu China 17 832 1.1× 372 0.9× 188 0.7× 174 0.7× 211 0.8× 45 1.4k
Wen-Jia Chen China 23 996 1.3× 523 1.2× 345 1.2× 192 0.7× 154 0.6× 101 1.6k
Xi Yu China 23 547 0.7× 243 0.6× 265 0.9× 202 0.8× 155 0.6× 64 1.4k
Anqi Li China 23 945 1.2× 343 0.8× 235 0.8× 115 0.4× 145 0.6× 97 1.4k
Jiangchao Li China 22 963 1.3× 553 1.3× 368 1.3× 157 0.6× 130 0.5× 72 1.6k
Bing-Rong Liu China 24 969 1.3× 427 1.0× 188 0.7× 336 1.3× 592 2.3× 108 2.1k
Xiaoqiong Gu China 16 522 0.7× 301 0.7× 104 0.4× 270 1.0× 221 0.9× 72 1.2k
Changhua Zhang China 25 1.2k 1.6× 676 1.6× 531 1.9× 335 1.3× 266 1.0× 89 2.0k
Yuan‐Li Huang Taiwan 30 1.1k 1.5× 548 1.3× 423 1.5× 196 0.7× 116 0.5× 87 2.1k

Countries citing papers authored by Ning Shi

Since Specialization
Citations

This map shows the geographic impact of Ning Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Shi more than expected).

Fields of papers citing papers by Ning Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Shi. The network helps show where Ning Shi may publish in the future.

Co-authorship network of co-authors of Ning Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Shi. A scholar is included among the top collaborators of Ning Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Shi. Ning Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Ying, Jia Li, Ning Shi, et al.. (2025). Research progress on intrinsic capacity in older adults: Concepts, epidemiology, assessments, influencing factors, adverse outcomes, and interventions. Global Health & Medicine. 7(5). 358–369. 1 indexed citations
2.
Shi, Ning, et al.. (2025). Anti-reflux mucosectomy for proton pump inhibitor refractory gastroesophageal reflux disease with hiatal hernia: A case report. Medicine. 104(8). e41166–e41166. 2 indexed citations
3.
Wang, Nan, et al.. (2025). Correlation between UGT1A1 polymorphism and efficacy and toxicity of irinotecan in Chinese cancer patients. Frontiers in Pharmacology. 16. 1563566–1563566.
4.
5.
Mo, Zhiqiang, Qiao Li, Jian He, et al.. (2024). Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy. Journal for ImmunoTherapy of Cancer. 12(1). e008191–e008191. 3 indexed citations
6.
Wang, Zhihong, Hui Dong, Ning Shi, et al.. (2024). Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2. Advanced Science. 11(45). e2402975–e2402975. 3 indexed citations
7.
Li, Shasha, Hui Liu, Weidong Liu, et al.. (2023). ESRG is critical to maintain the cell survival and self-renewal/pluripotency of hPSCs by collaborating with MCM2 to suppress p53 pathway. International Journal of Biological Sciences. 19(3). 916–935. 11 indexed citations
8.
9.
Jiang, Shuai, et al.. (2023). Evaluation of HER-2 positive breast cancer treated with dual-targeted treatment of trastuzumab plus pertuzumab. Immunopharmacology and Immunotoxicology. 45(5). 616–625. 3 indexed citations
10.
Li, Cheng‐Hui, Wei Wang, Pengpeng Xiao, et al.. (2023). Metavirome Analysis and Identification of Midge-Borne Viruses from Yunnan Province, China, in 2021. Viruses. 15(9). 1817–1817. 1 indexed citations
11.
Shi, Ning, Jing Zhang, & Shi‐You Chen. (2023). DOCK2 Promotes Asthma Development by Eliciting Airway Epithelial–Mesenchymal Transition. American Journal of Respiratory Cell and Molecular Biology. 69(3). 310–320. 8 indexed citations
12.
Tang, Rui, Xiaohan Mei, Ning Shi, et al.. (2020). LncRNA GAS5 attenuates fibroblast activation through inhibiting Smad3 signaling. American Journal of Physiology-Cell Physiology. 319(1). C105–C115. 30 indexed citations
13.
Yin, Zi, Yu Zhou, Tingting Ma, et al.. (2020). Down‐regulated lncRNA SBF2‐AS1 in M2 macrophage‐derived exosomes elevates miR‐122‐5p to restrict XIAP, thereby limiting pancreatic cancer development. Journal of Cellular and Molecular Medicine. 24(9). 5028–5038. 102 indexed citations
14.
Lian, Haifeng, Ning Shi, Shuyang Xie, et al.. (2018). Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4. Cancer Management and Research. Volume 10. 6129–6141. 15 indexed citations
15.
16.
Cui, Xiaogang, Brett Marshall, Ning Shi, et al.. (2017). RNA-Seq analysis on chicken taste sensory organs: An ideal system to study organogenesis. Scientific Reports. 7(1). 9131–9131. 13 indexed citations
17.
18.
Shi, Ning, Xia Guo, & Shi‐You Chen. (2014). Olfactomedin 2, a novel regulator for transforming growth factor-β–induced smooth muscle differentiation of human embryonic stem cell–derived mesenchymal cells. Molecular Biology of the Cell. 25(25). 4106–4114. 29 indexed citations
19.
Shi, Ning & Shi‐You Chen. (2014). Mechanisms simultaneously regulate smooth muscle proliferation and differentiation. Journal of Biomedical Research. 28(1). 40–40. 78 indexed citations
20.
Shi, Ning, et al.. (2002). Estimation and Test of ARCH(0,2) Model under Order Restriction. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianxian Wu Breakdown of academic impact, for papers by Wen-Jia Chen Breakdown of academic impact, for papers by Xi Yu Breakdown of academic impact, for papers by Anqi Li Breakdown of academic impact, for papers by Jiangchao Li Breakdown of academic impact, for papers by Bing-Rong Liu Breakdown of academic impact, for papers by Xiaoqiong Gu Breakdown of academic impact, for papers by Changhua Zhang Breakdown of academic impact, for papers by Yuan‐Li Huang
Rankless by CCL
2026